Paper · 165258
Neutrophil-mediated tumor cell cytotoxicity: role of the peroxidase system.
Clark RA and 1 other. J Exp Med, 1975. Cited by 353 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Neutrophil-mediated tumor cell cytotoxicity: role of the peroxidase system. Papers, record 165258. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/165258
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neutrophils | Major topic |
| Peroxidase | Major topic |
| Peroxidases | Major topic |
| Animals | |
| Azides | |
| Catalase | |
| Chlorides | |
| Chromium Radioisotopes | |
| Cyanides | |
| Cytotoxicity Tests, Immunologic | |
| Glucosephosphate Dehydrogenase Deficiency | |
| Granulomatous Disease, Chronic | |
| Humans | |
| Hydrogen Peroxide | |
| Iodides | |
| Lymphoma | |
| Male | |
| Mice | |
| Mice, Inbred BALB C | |
| Opsonin Proteins | |
| Phagocytosis | |
| Zymosan |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References17
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 5,129,301 | Oxidant injury of caucasian glucose-6-phosphate dehydrogenase-deficient red blood cells by phagocytosing leukocytes during infection. | J Clin Invest | 1971 | https://conductscience.org/library/papers/5129301 | PubMed |
| 2 | 5,522,855 | A uterine fluid-mediated sperm-inhibitory system. | Biol Reprod | 1970 | https://conductscience.org/library/papers/5522855 | PubMed |
| 3 | 5,765,020 | Degranulation of leukocytes in chronic granulomatous disease. | J Clin Invest | 1969 | https://conductscience.org/library/papers/5765020 | PubMed |
| 4 | 5,796,360 | Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection. | J Clin Invest | 1969 | https://conductscience.org/library/papers/5796360 | PubMed |
| 5 | 1,118,738 | Antimicrobial mechanisms in neutrophilic polymorphonuclear leukocytes. | Semin Hematol | 1975 | https://conductscience.org/library/papers/1118738 | PubMed |
| 6 | 1,120,184 | Peroxidase-H2O2-halide system: Cytotoxic effect on mammalian tumor cells. | Blood | 1975 | https://conductscience.org/library/papers/1120184 | PubMed |
| 7 | 4,125,296 | Neutrophil dysfunction, chronic granulomatous disease, and non-spherocytic haemolytic anaemia caused by complete deficiency of glucose-6-phosphate dehydrogenase. | Lancet | 1973 | https://conductscience.org/library/papers/4125296 | PubMed |
| 8 | 4,131,165 | An in vitro study of exocytosis of neutrophil granule enzymes in chronic granulomatous disease neutrophils. | J Immunol | 1974 | https://conductscience.org/library/papers/4131165 | PubMed |
| 9 | 4,340,975 | Leukocytic proteases and the immunologic release of lysosomal enzymes. | Am J Pathol | 1972 | https://conductscience.org/library/papers/4340975 | PubMed |
| 10 | 4,372,270 | Modulation of polymorphonuclear leukocyte-mediated antibody-dependent cellular cytotoxicity. | J Immunol | 1974 | https://conductscience.org/library/papers/4372270 | PubMed |
1 to 10 of 17
See all 17 referencesCited by109
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 353 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,979,333 | Targeting cancer-associated neutrophils with biomimetic nano-vaccines loaded with mRNA can enhance the efficacy of immunotherapy for hepatocellular carcinoma. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42979333 | PubMed |
| 42,023,239 | Tumor-associated neutrophils in pancreatic ductal adenocarcinoma: mechanisms and therapeutic targeting. | Front Immunol | 2026 | https://conductscience.org/library/papers/42023239 | PubMed |
| 41,499,552 | IL10R Inhibition Induces Neutrophil Tumoricidal Activity. | Cancer Immunol Res | 2026 | https://conductscience.org/library/papers/41499552 | PubMed |
| 40,528,159 | Targeting circulating tumor cell‒neutrophil interactions: nanoengineered strategies for inhibiting cancer metastasis. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/40528159 | PubMed |
| 40,187,604 | TRAIL induces cytokine production via the NFkB2 pathway promoting neutrophil chemotaxis and neutrophil-mediated immune-suppression in triple negative breast cancer cells. | Cancer Lett | 2025 | https://conductscience.org/library/papers/40187604 | PubMed |
| 39,941,753 | Neutrophil Engulfment in Cancer: Friend or Foe? | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/39941753 | PubMed |
| 39,814,410 | NADPH oxidases: redox regulation of cell homeostasis and disease. | Physiol Rev | 2025 | https://conductscience.org/library/papers/39814410 | PubMed |
| 39,567,761 | The diverse roles of neutrophils from protection to pathogenesis. | Nat Immunol | 2024 | https://conductscience.org/library/papers/39567761 | PubMed |
| 39,222,166 | CD24 affects the immunosuppressive effect of tumor-infiltrating cells and tumor resistance in a variety of cancers. | Discov Oncol | 2024 | https://conductscience.org/library/papers/39222166 | PubMed |
| 38,846,085 | β-Lapachone promotes the recruitment and polarization of tumor-associated neutrophils (TANs) toward an antitumor (N1) phenotype in NQO1-positive cancers. | Oncoimmunology | 2024 | https://conductscience.org/library/papers/38846085 | PubMed |
1 to 10 of 109
See all 109 cited byGenes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CAT | 847 | PubTator's text mining | https://conductscience.org/library/genes/847 | NCBI Gene |
| MPO | 4,353 | PubTator's text mining | https://conductscience.org/library/genes/4353 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/165258
GET https://conductscience.org/api/papers/v1/165258/cited_by?page=2